Top 3 Tech Stocks That May Rocket Higher This Quarter

Several information-technology names are trading technically oversold (RSI near/below 30) after recent analyst action and price drops, presenting potential tactical buying opportunities. Goldman Sachs downgraded Arm (ARM) to Sell on Dec. 15 and cut the PT from $160 to $120; ARM is down ~15% over the past month, trading at $114.03 with an RSI of 27.3 and a 52-week low of $80. Crane NXT (CXT) saw Baird lower its target to $82 while keeping Outperform; CXT is down ~14% over the month, closing $47.20 with an RSI of 26.7. BlackBerry reported Q3 revenue of $141.8m (vs. $137.4m est.) and adjusted EPS of $0.05 (vs. $0.04 est.) but shares plunged ~12.9% to $3.77 and carry an RSI of 24, signaling continued investor caution despite the beat.

Analysis

Market structure: The sharp RSI-driven selloffs (ARM RSI 27.3, CXT 26.7, BB 24) signal forced short-term liquidation and a rotation out of small/mid-cap tech into quality or cash. Winners: large-cap AI/IP beneficiaries (NVIDIA, MSFT) and fixed income if risk-off deepens; losers: licensing/IP-exposed names (ARM) and niche software/hardware plays with high customer concentration. Options vol has risen — expect >10–30% higher IV for tactical hedges.

Risk assessment: Tail risks include a licensing slowdown or customer design losses for ARM (revenue hit >10% would be high-impact), government/regulatory actions on telecom/security for BB, and order cancellations for CXT. Immediate (days) — potential technical bounce; short-term (weeks/months) — earnings, analyst revisions and holiday-season flows; long-term (quarters/years) — secular AI and embedded compute demand that can restore ARM pricing power.

Trade implications: Favor small, asymmetric exposures: selective longs sized 1–3% with hard stops and option overlays rather than large directional bets. Relative-value: prefer buying idiosyncratic weakness (CXT, BB) and hedge beta with an index/ETF short. Entry triggers: ARM < $115, CXT < $50, BB < $4; tighten stops near 20–25% downside and targets 30–60% upside within 3–12 months.

Contrarian angles: Consensus is pricing permanent deceleration; that understates ARM’s multi-year royalty leverage to AI chips and BB’s recent profit/cash-flow inflection. The reaction may be overdone if next 2–3 quarters show stable licensing cadence or renewed corporate contracts. Risk: further macro selloffs could still push these names to their 52-week lows first (ARM $80, BB $2.80).

Key Decisions for Investors

• Establish a 1.5–2% long position in ARM (ARM) on weakness ≤ $115 with a stop-loss at $95 and a target of $140 within 3–6 months; alternatively buy a 6-month 110/140 call spread to cap downside and allow 30%+ upside capture.
• Take a speculative 1% position in BlackBerry (BB) if price trades below $4, size with a hard stop at $2.80; pair this with buying a 3-month $4 OTM call to limit capital at risk and target $6 in 3–6 months if cash flow guidance remains stable.
• Initiate a 2% long in Crane NXT (CXT) below $50 with stop at $42 and a 6–12 month target of $75; hedge idiosyncratic beta by shorting 0.5% notional of the iShares U.S. Technology ETF (IYW) to isolate stock-specific recovery.
• If implied volatility > realized by >30% and you are willing to own shares, sell cash-secured puts 10–15% below current levels on ARM or CXT (size to limit assignment to 2–3% portfolio exposure). Monitor ARM licensing/cadence announcements within 30 days, BB cash-flow/contract updates at next quarter, and CXT backlog/order news over 60–90 days as primary catalysts.